Discover more from Resisting the Intellectual Illiteratti
Vaccine Roulette: Making Outright Human Experimentation Great Again (Part 1)
Case reports where the patient was given dose #2 despite suffering an SAE following dose #1
Welcome to the Post-Nuremberg Ethical Apocalypse: Dose 1 Severe Adverse Event, Dose 2...? You'll have to get jabbed with Dose 2 to find out
This is not an exaggeration. It is one thing for doctors to get brainwashed to believe that the newly minted miracle covid ‘vaccines’ were, well, miraculous; the whole “safe and effective” canard. It is another matter entirely for doctors to conduct what amounts to ad hoc human experimentation by giving a second (or third) dose of a novel therapeutic to a patient who suffered an obvious clinical event following the preceding dose. There was no clinical data of any sort available regarding the safety profile of giving this product to someone who had just suffered a severe clinical event, whether or not it was caused by the administration of the first dose. And the data on the real-world benefit of getting a second dose over sticking with just the first dose was sparse, to say the least.
Yet as we shall see, numerous clinicians went ahead and decided to recommend to patients who suffered an adverse clinical episode following dose #1 that they should proceed with dose #2.
In other words, doctors were giving a drug to patients where there was:
no safety data whatsoever at the time concerning someone with that medical profile
little if any efficacy data on the absolute benefit of dose 2 vs remaining only single-dosed
no way of knowing that the drug was NOT responsible for the adverse event that coincidentally occurred following the administration of dose #1
Siri, what word is defined as “an operation or procedure carried out under controlled conditions in order to discover an unknown effect or law”?
Below (and in subsequent installments in this series) are some of the case reports that I have come across where the patient was given dose #2 after suffering a Severe Adverse Event (SAE) following dose #1.
Quick primer on the formatting:
I divided case reports into “Winners” & “Losers” based on whether dose #2 caused new or worsening of the SAE’s following dose #1.
Yes, sometimes the patient gets dose #2 without suffering any SAE, at least in the short term, hence the title “Vaccine Roulette”.
Obviously, surviving dose #2 without further injury does not suggest that it was a good idea to get dose #2 - this would be akin to claiming that playing real Russian Roulette is harmless because you survived.
Each report has the case report title, link, timeline of events, and some ‘commentary’; I also am including the excerpts from the case report describing the basic narrative of the case in a footnote placed at the end of the link
I have identified a few dozen of these case reports so far from the case reports that I have cataloged in detail, However, I have only cataloged about 350-400 or so out of the 2,360+ (and growing) that I have compiled to date.
Repeated Cardioembolic Stroke after COVID-19 mRNA Vaccination: A Case Report
At least the physicians entertained that maybe - just maybe - the vaccine might have had something to do with the synchronous strokes occurring precisely 3 days after both doses.
Development of Venous Thromboembolism After COVID-19 mRNA-1273 Vaccine Inoculation
79yo M: D1: M dose 1 D4: Pain/swelling right leg, doc orders ultrasound 😫 D5-D28: US scheduling delay 😫 D29: M dose 2 😱 D29: Symptoms worsen 😨🙄 D30: Ultrasound finds "extensive DVT" 😱💣
So yeah, patient developed pain 3 days after Moderna Dose #1 that was bad enough to warrant an ultrasound. But scheduling is just sooo hard, especially amidst lockdown restrictions. Until after dose #2 that is, when it became so intolerable that the docs had a newfound sense of urgency to figure out what was going on.
Guillain‐Barré syndrome after mRNA‐1273 (Moderna) COVID‐19 vaccination: A case report
80yo Male: D1: M dose 1 D2-D28 (approx): numerous neurological symptoms 😨😫 D29 (approx): M dose 2 😱😓 D30 (approx): "unable to get out of his bed" 😱💣😱💣😱💣
This patient had clear and obvious neurological problems immediately following dose 1. His symptoms got progressively worse leading up to dose 2 (“progressive bilateral lower limb distal weakness, beginning at his feet and then ascending to involve his legs, knees, and hips”).
So of course, the doctors figured that yeah, totally he needs dose #2.
Dose 2 immediately relieved the poor patient of what little motor function he had left in his legs altogether.
“Physicians should remain vigilant for GBS following COVID‐19 vaccination”.
You don’t say? Does vigilant mean like how you were so super duper vigilant after the initial GBS symptoms manifestation after Dose #1? Did the clinical team hold off from doing proper neurological tests until after Dose #2 because they didn’t want to “risk” having to forgo Dose #2? Good questions. That we may never get a clear answer for.
Post coronavirus disease-2019 vaccination Guillain-Barré syndrome
49yo Male: D1: AZ dose 1 D8: GBS symtpom onset 😮😨 D12 (approx): Hospitalized 😣 D25 (approx): Discharged after some improvement 😕😥 D50: AZ dose 2 😱😱 D51+: ????🤔🤔🤔
No, you’re not missing anything, they don’t tell us if there was any clinical impact on symptoms from Dose #2. I can’t help but wonder if Dose #2 might be hampering recovery?
But seriously, how deranged is it to give the patient Dose #2 WHILE HE STILL HAD NOT YET RECOVERED FROM THE DOSE #1 GBS????
Sequential contralateral facial nerve palsies following COVID-19 vaccination first and second doses
61yo Male: D1: Pf dose 1 D1 + 5hr: Bell's Palsy #1 😮😱 D30 (approx): 'complete' resolution of palsy #1 😅😍 D43 (approx): Pf dose 2 😱😨😱 D45: Bell's Palsy #2 'new & improved' (ie worse)💣💣💣💣💣💣💣
“The patient has been advised to discuss future mRNA vaccines with the GP on a case-by-case basis, taking into account risk versus benefit of having each vaccine.”
Well at least ‘discuss’ is a step in the right direction 😂🤔🤔.
Did the patient really have to get dose #2? Just because you cured the Bell’s Palsy the 1st time means that you can cure every subsequent occurrence?
Bizarrely, the authors wrote this up almost as though it was an accomplishment:
“We describe the first case of Bell’s palsy occurring after each dose of any UK-approved COVID-19 vaccine”
“Single episodes of unilateral facial nerve palsies have been reported in clinical trials and in subsequent case reports. There has been no evidence, however, of an episode after each dose.”
This deficiency in the data is now deficient no longer. Points for SCIENCE!!
The title says it all on this one…..
Vestibular neuronitis after COVID-19 vaccination
50's Female D1: Pf dose 1 D3: symptom onset including vomiting, vertigo, unsteady gait, light-headedness, drowsiness 🤢🤮 D57: Fully recovered 😅😍 D>58: Pf dose 2 😨😱 D>58+: No complications 😍🥳🥳🥳🥳
It only took 6 weeks to recover from the probable Dose #1 SAE. So she can really savor the sweet, sweet taste of vaccine protection she acquired through lots of blood, sweat & tears. Probably copious amounts of the latter two.
The protection lasts about as long as her recover from Dose #1 did too!
Kudos to her doctors though, they actually waited for her to have a complete recovery, which is no small act of defiance against the vaccine cult.
Resisting the Intellectual Illiteratti is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
An 83-year-old Japanese woman developed right hemiplegia and motor aphasia three days after receiving her first dose of the BNT162b2 (Pfizer) COVID-19 mRNA vaccine. She had been taking rivaroxaban for persistent atrial fibrillation for 10 years, but had no symptomatic ischemic strokes. On magnetic resonance imaging (MRI) the left middle cerebral artery (MCA) was occluded. Intravenous recombinant tissue-plasminogen activator (rt-PA) therapy and mechanical thrombectomy were performed, and she recovered almost fully. However, three days after the second dose, she developed left hemiplegia and left hemispatial neglect. MRI showed occlusion of the right MCA. Only mechanical thrombectomy was performed again, but it could not be resumed due to the hard thrombus.
A 79-year-old male with an unremarkable past medical history and completed lifetime health screenings had his first dose of the mRNA-1273 COVID-19 vaccine on May 12, 2021. Three days later, he developed some pain with swelling in his right lower extremity (RLE) below the knee. He was seen by his primary care physician who ordered a duplex venous ultrasound of the lower extremities; however, it was delayed because of scheduling problems. Meanwhile, he proceeded to receive his 2nd dose of the mRNA-1273 COVID vaccine 28 days after the 1st vaccine dose on June 9, 2021. Worsening of his RLE pain and increased shortness of breath led him to complete the venous doppler ultrasound on June 10, 2021, where an extensive DVT was found along the RLE (Figures (Figures11--44).
We present a case of 80‐year‐old male patient who presented with chief complaints of progressive, ascending bilateral lower extremity paresthesia and weakness following first dose of Moderna vaccine. His symptoms got exacerbated after 2nd dose. Clinical examination and investigation findings including lumbar puncture, nerve conduction study, and electromyography were consistent with the diagnosis of GBS. The patient received treatment with intravenous immunoglobulin and there was significant improvement toward the end of 5th day. Though rare, this case report suggest that physician should remain vigilant for GBS following COVID‐19 vaccination.
After 1 week from receiving 1st dose of the vaccine, he developed weakness in bilateral lower limb that progressed rapidly and within 2–3 days he also noticed weakness of the bilateral upper limb with the inability to perform fine finger movement. At the same time, he was having bilateral facial muscle weakness, leading to difficulty in speech and swallowing.
The patient was taken home after 13 days of the hospital stay and continued therapeutic rehabilitation exercises for facial muscle and all four limbs at home. There was complete recovery of lower-limb and facial muscle strength but there was no improvement in upper-limb strength. On a follow-up visit after 3 months from discharge, power of all muscles of both lower limbs is 5/5 according to the Medical Research Council scale. There was weakness in both the upper limb (left > right) and weakness was more profound at distal upper-limb muscles [Table 1].
We advised shoulder sling along with physiotherapy and occupational therapy to prevent and treat shoulder subluxation, to improve the strength of weak muscles and to improve ADL. This patient is still being followed up at regular intervals at our outpatient department for subsequent supervision and monitoring.
A 61-year-old man presented to the ENT emergency clinic with a history of unilateral facial nerve palsy occurring shortly after each dose of the Pfizer-BioNTech COVID-19 vaccine. The first episode developed 5 hours after administration of the first dose and the second 2 days after administration of the second dose. Investigations at initial presentation to the emergency department were unremarkable, and the patient was diagnosed with Bell’s palsy on both occasions. We describe the first case of Bell’s palsy occurring after each dose of any UK-approved COVID-19 vaccine. Single episodes of unilateral facial nerve palsies have been reported in clinical trials and in subsequent case reports. There has been no evidence, however, of an episode after each dose. We also describe the earliest onset of symptoms from timing of administration of the vaccine, further suggesting the Bell’s palsy was associated with the vaccine.
A woman in her 50s presented with acute vertigo and vomiting within 72 hours of receiving the Pfizer-BioNTech COVID-19 vaccine. The only neurological deficit was an impaired vestibulo-ocular reflex with horizontal nystagmus. The patient was subsequently diagnosed with vestibular neuronitis. She was managed symptomatically with prochlorperazine and betahistine, and underwent vestibular rehabilitation for 6 weeks. She made a full recovery and experienced no further symptoms. She received the second dose of the vaccine without complications.